Type 1 Diabetes
Top in endocrinology: Type 1 diabetes drug approval; hedonic hunger
Last week, the FDA announced that it has approved Tzield to delay the onset of type 1 diabetes in adults and children aged 8 years and older with stage 2 type 1 diabetes.
FDA approves teplizumab to delay type 1 diabetes onset
The FDA has approved teplizumab to delay the onset of type 1 diabetes for both adults and children aged 8 years and older with stage 2 type 1 diabetes, according to an agency press release.
FDA approves teplizumab to delay type 1 diabetes onset
The FDA has approved teplizumab to delay the onset of type 1 diabetes for both adults and children aged 8 years and older with stage 2 type 1 diabetes, according to an agency press release.
Diabetes incidence higher among young people with vs. without Down syndrome
Children, adolescents and young adults with Down syndrome have higher incidence rates of type 1 and type 2 diabetes compared with matched controls without Down syndrome, according to a study published in Diabetes Care.
Continuous glucose monitoring use increasing among young people, linked to lower HbA1c
Use of continuous glucose monitoring among children and young adults with type 1 diabetes nearly doubled from 2017 to 2020 in the U.S. from 25% to 49% and was associated with lower HbA1c for users vs. non-users, according to registry data.
Earlier diabetes diagnosis linked to younger age at natural menopause
Women diagnosed with type 1 diabetes before age 30 years or type 2 diabetes at age 30 to 39 years are more likely to reach menopause earlier than women without diabetes, according to study results.
Costs associated with type 1 diabetes affect physical, emotional health of young adults
Rise in diabetes costs, including increased insulin prices, substantially influenced physical and psychological health for young adults with type 1 diabetes, according to survey results published in Diabetes Technology & Therapeutics.
Type 1 diabetes index estimates global burden of disease to 2040
JDRF released a data simulation tool to measure the global human and public health impacts of type 1 diabetes to aid in identifying regional interventions that may lead to cures, researchers reported.
Girls with type 1 diabetes lose trabecular bone volume
Adolescent girls with type 1 diabetes lost trabecular volumetric bone mineral density over 1 year compared with gains for girls without diabetes, with greater loss at higher HbA1c levels, according to a speaker.
Subcutaneous insulin therapy cost-effective for mild DKA for children with type 1 diabetes
Subcutaneous insulin therapy was associated with shorter hospital stay and lower cost vs. intravenous insulin infusion for the treatment of mild diabetic ketoacidosis for children with type 1 diabetes, according to study data.